Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1173121
PUBLISHER: KBV Research | PRODUCT CODE: 1173121
Europe AI In Cancer Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user, By Component, By Cancer Type, By Country and Growth Forecast, 2022 - 2028
PUBLISHED:
PAGES: 86 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Europe AI In Cancer Diagnostics Market would witness market growth of 28.0% CAGR during the forecast period (2022-2028).
AI technologies would be applied to crucial oncogenes. Early detection and treatment of cancer improve the chances of a cure. Some cancer cases, such as mouth, skin, testicles, breast, rectum, and prostate can be easily detected by the self-routine checkup and various screening measures before cancer becomes more dangerous and harmful.
Generally, most cancer cases are identified and discovered after the tumor can be perceptible or when other symptoms start appearing. Cancer can also be discovered by treating or examining other medical issues however these happen in a few cases. Cancer can be discovered through the reported testing of the urine, blood, and Stoll abnormalities which may sign of cancer case.
The cases of the neck postmortem are a standard check for the therapy of oral cavity cancer in the authorized head and neck cancer clinics established in Germany. 76% of instances of oral cavity cancer treated in certified centers will involve neck dissections. Head and neck cancers account for about 4% of all tumors in the US. Government spending on healthcare has upraised up to 4% annually in the United Kingdom. During the 1960s, the gross domestic product of healthcare products portraited less than 5% whereas after more than fifty years the GDP hiked up to 10%.
The Germany market dominated the Europe AI In Cancer Diagnostics Market by Country in 2021; thereby, achieving a market value of $33.8 million by 2028. The UK market is exhibiting a CAGR of 27% during (2022 - 2028). Additionally, The France market would experience a CAGR of 29% during (2022 - 2028).
Based on End-user, the market is segmented into Hospital, Surgical Centers & Medical Institutes and Others. Based on Component, the market is segmented into Software Solutions, Hardware and Services. Based on Cancer Type, the market is segmented into Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer & Cervical Cancer, Prostate & Colorectal Cancer and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.
Scope of the Study
Market Segments covered in the Report:
By End-user
- Hospital
- Surgical Centers & Medical Institutes
- Others
By Component
- Software Solutions
- Hardware
- Services
By Cancer Type
- Breast Cancer
- Lung Cancer
- Brain Tumor
- Skin Cancer & Cervical Cancer
- Prostate & Colorectal Cancer
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Microsoft Corporation
- Flatiron Health
- Paige AI, Inc.
- PathAI, Inc.
- Therapixel
- Tempus, Inc.
- SkinVision BV
- Cancer Center Sp. z o.o.
- Medial EarlySign
- Kheiron Medical Technologies Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe AI In Cancer Diagnostics Market, by End-user
- 1.4.2 Europe AI In Cancer Diagnostics Market, by Component
- 1.4.3 Europe AI In Cancer Diagnostics Market, by Cancer Type
- 1.4.4 Europe AI In Cancer Diagnostics Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenarios
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players
Chapter 4. Europe AI In Cancer Diagnostics Market by End-user
- 4.1 Europe Hospital Market by Country
- 4.2 Europe Surgical Centers & Medical Institutes Market by Country
- 4.3 Europe Others Market by Country
Chapter 5. Europe AI In Cancer Diagnostics Market by Component
- 5.1 Europe Software Solutions Market by Country
- 5.2 Europe Hardware Market by Country
- 5.3 Europe Services Market by Country
Chapter 6. Europe AI In Cancer Diagnostics Market by Cancer Type
- 6.1 Europe Breast Cancer Market by Country
- 6.2 Europe Lung Cancer Market by Country
- 6.3 Europe Brain Tumor Market by Country
- 6.4 Europe Skin Cancer & Cervical Cancer Market by Country
- 6.5 Europe Prostate & Colorectal Cancer Market by Country
- 6.6 Europe Others Market by Country
Chapter 7. Europe AI In Cancer Diagnostics Market by Country
- 7.1 Germany AI In Cancer Diagnostics Market
- 7.1.1 Germany AI In Cancer Diagnostics Market by End-user
- 7.1.2 Germany AI In Cancer Diagnostics Market by Component
- 7.1.3 Germany AI In Cancer Diagnostics Market by Cancer Type
- 7.2 UK AI In Cancer Diagnostics Market
- 7.2.1 UK AI In Cancer Diagnostics Market by End-user
- 7.2.2 UK AI In Cancer Diagnostics Market by Component
- 7.2.3 UK AI In Cancer Diagnostics Market by Cancer Type
- 7.3 France AI In Cancer Diagnostics Market
- 7.3.1 France AI In Cancer Diagnostics Market by End-user
- 7.3.2 France AI In Cancer Diagnostics Market by Component
- 7.3.3 France AI In Cancer Diagnostics Market by Cancer Type
- 7.4 Russia AI In Cancer Diagnostics Market
- 7.4.1 Russia AI In Cancer Diagnostics Market by End-user
- 7.4.2 Russia AI In Cancer Diagnostics Market by Component
- 7.4.3 Russia AI In Cancer Diagnostics Market by Cancer Type
- 7.5 Spain AI In Cancer Diagnostics Market
- 7.5.1 Spain AI In Cancer Diagnostics Market by End-user
- 7.5.2 Spain AI In Cancer Diagnostics Market by Component
- 7.5.3 Spain AI In Cancer Diagnostics Market by Cancer Type
- 7.6 Italy AI In Cancer Diagnostics Market
- 7.6.1 Italy AI In Cancer Diagnostics Market by End-user
- 7.6.2 Italy AI In Cancer Diagnostics Market by Component
- 7.6.3 Italy AI In Cancer Diagnostics Market by Cancer Type
- 7.7 Rest of Europe AI In Cancer Diagnostics Market
- 7.7.1 Rest of Europe AI In Cancer Diagnostics Market by End-user
- 7.7.2 Rest of Europe AI In Cancer Diagnostics Market by Component
- 7.7.3 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type
Chapter 8. Company Profiles
- 8.1 Microsoft Corporation
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 SWOT Analysis
- 8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 Recent strategies and developments:
- 8.2.5.1 Partnerships, Collaborations, and Agreements:
- 8.3 Paige AI, Inc.
- 8.3.1 Company Overview
- 8.3.2 Recent strategies and developments:
- 8.3.2.1 Partnerships, Collaborations, and Agreements:
- 8.3.2.2 Product Launches and Product Expansions:
- 8.4 PathAI, Inc.
- 8.4.1 Company Overview
- 8.4.2 Recent strategies and developments:
- 8.4.2.1 Partnerships, Collaborations, and Agreements:
- 8.4.2.2 Acquisition and Mergers:
- 8.5 Therapixel
- 8.5.1 Company Overview
- 8.5.2 Recent strategies and developments:
- 8.5.2.1 Product Launches and Product Expansions:
- 8.6 Tempus, Inc.
- 8.6.1 Company Overview
- 8.6.2 Recent strategies and developments:
- 8.6.2.1 Partnerships, Collaborations, and Agreements:
- 8.7 SkinVision BV
- 8.7.1 Company Overview
- 8.8 Cancer Center Sp. z o.o.
- 8.8.1 Company Overview
- 8.9 Medial EarlySign
- 8.9.1 Company Overview
- 8.10. Kheiron Medical Technologies Limited
- 8.10.1 Company Overview
- 8.10.2 Recent strategies and developments:
- 8.10.2.1 Partnerships, Collaborations, and Agreements:
LIST OF TABLES
- TABLE 1 Europe AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 2 Europe AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 3 Partnerships, Collaborations and Agreements- AI In Cancer Diagnostics Market
- TABLE 4 Product Launches And Product Expansions- AI In Cancer Diagnostics Market
- TABLE 5 Acquisition and Mergers- AI In Cancer Diagnostics Market
- TABLE 6 Europe AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 7 Europe AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 8 Europe Hospital Market by Country, 2018 - 2021, USD Thousands
- TABLE 9 Europe Hospital Market by Country, 2022 - 2028, USD Thousands
- TABLE 10 Europe Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
- TABLE 11 Europe Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
- TABLE 12 Europe Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 13 Europe Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 14 Europe AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 15 Europe AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 16 Europe Software Solutions Market by Country, 2018 - 2021, USD Thousands
- TABLE 17 Europe Software Solutions Market by Country, 2022 - 2028, USD Thousands
- TABLE 18 Europe Hardware Market by Country, 2018 - 2021, USD Thousands
- TABLE 19 Europe Hardware Market by Country, 2022 - 2028, USD Thousands
- TABLE 20 Europe Services Market by Country, 2018 - 2021, USD Thousands
- TABLE 21 Europe Services Market by Country, 2022 - 2028, USD Thousands
- TABLE 22 Europe AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 23 Europe AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 24 Europe Breast Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 25 Europe Breast Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 26 Europe Lung Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 27 Europe Lung Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 28 Europe Brain Tumor Market by Country, 2018 - 2021, USD Thousands
- TABLE 29 Europe Brain Tumor Market by Country, 2022 - 2028, USD Thousands
- TABLE 30 Europe Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 31 Europe Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 32 Europe Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 33 Europe Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 34 Europe Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 35 Europe Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 36 Europe AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
- TABLE 37 Europe AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
- TABLE 38 Germany AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 39 Germany AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 40 Germany AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 41 Germany AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 42 Germany AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 43 Germany AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 44 Germany AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 45 Germany AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 46 UK AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 47 UK AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 48 UK AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 49 UK AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 50 UK AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 51 UK AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 52 UK AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 53 UK AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 54 France AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 55 France AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 56 France AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 57 France AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 58 France AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 59 France AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 60 France AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 61 France AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 62 Russia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 63 Russia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 64 Russia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 65 Russia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 66 Russia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 67 Russia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 68 Russia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 69 Russia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 70 Spain AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 71 Spain AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 72 Spain AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 73 Spain AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 74 Spain AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 75 Spain AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 76 Spain AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 77 Spain AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 78 Italy AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 79 Italy AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 80 Italy AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 81 Italy AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 82 Italy AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 83 Italy AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 84 Italy AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 85 Italy AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 86 Rest of Europe AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 87 Rest of Europe AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 88 Rest of Europe AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 89 Rest of Europe AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 90 Rest of Europe AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 91 Rest of Europe AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 92 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 93 Rest of Europe AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 94 key information - Microsoft Corporation
- TABLE 95 Key Information - Flatiron Health
- TABLE 96 Key Information -Paige AI, Inc.
- TABLE 97 Key Information - PathAI, Inc.
- TABLE 98 Key Information -Therapixel
- TABLE 99 Key Information - Tempus, Inc.
- TABLE 100 Key Information - SkinVision BV
- TABLE 101 Key Information - Cancer Center Sp. z o.o.
- TABLE 102 Key Information - Medial EarlySign
- TABLE 103 Key Information - Kheiron Medical Technologies Limited
List of Figures
- FIG 1 Methodology for the research
- FIG 2 KBV Cardinal Matrix
- FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
- FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players
- FIG 5 SWOT Analysis: Microsoft Corporation
- FIG 6 Recent strategies and developments: Paige AI, Inc.
- FIG 7 Recent strategies and developments: PathAI, Inc.
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.